Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $337,949 - $382,839
-9,411 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $36,202 - $40,829
1,081 Added 12.98%
9,411 $341,000
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $289,247 - $367,803
-8,642 Reduced 50.92%
8,330 $307,000
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $68,135 - $79,938
-2,146 Reduced 11.23%
16,972 $623,000
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $1,114 - $1,351
-37 Reduced 0.19%
19,118 $625,000
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $430,804 - $615,525
15,938 Added 495.43%
19,155 $625,000
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $42,598 - $48,343
-1,294 Reduced 28.69%
3,217 $126,000
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $844 - $1,095
26 Added 0.58%
4,511 $162,000
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $183,679 - $206,229
-4,967 Reduced 52.55%
4,485 $194,000
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $1.39 Million - $1.52 Million
-36,950 Reduced 79.63%
9,452 $401,000
Q4 2018

Feb 06, 2019

BUY
$38.47 - $43.86 $14,695 - $16,754
382 Added 0.83%
46,402 $2.03 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $281,861 - $341,880
-8,177 Reduced 15.09%
46,020 $2.03 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $1.71 Million - $1.82 Million
51,891 Added 2250.26%
54,197 $1.97 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $1.61 Million - $1.86 Million
-50,320 Reduced 95.62%
2,306 $0
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $85,511 - $90,730
-2,571 Reduced 4.66%
52,626 $1.91 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $1.71 Million - $1.88 Million
55,197
55,197 $1.97 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sun Life Financial Inc Portfolio

Follow Sun Life Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sun Life Financial Inc with notifications on news.